Skip to content

Evaluation of tumour bed localisation and image-guided radiotherapy techniques for breast radiotherapy

Evaluation of tumour bed localisation and image-guided radiotherapy techniques for breast radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18654225
Enrollment
60
Registered
2006-08-03
Start date
2005-11-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Cancer Malignant neoplasm of breast

Interventions

1. Imaging investigations (with radiation) 2. Additional portal imaging field and Computed Tomography (CT) scan 3. Insertion of gold breast markers at surgery

Sponsors

Cambridge University Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Histological confirmation of invasive carcinoma 2. Operable unilateral breast cancer requiring breast conservation surgery 3. Patient unlikely to require chemotherapy based on biopsy results 4. Patient characteristics e.g. grade 1-2, aged more than 50 years, oestrogen receptor positive, tumours less than 4 cm

Exclusion criteria

Exclusion criteria: 1. Patients requiring mastectomy: there will be no tumour bed to localise 2. Patients likely to require chemotherapy prior to radiotherapy: we wish to complete the study within six months and chemotherapy patients require six months of treatment before radiotherapy is started. In addition, there is considerable shrinkage of the tumour bed after six months as a consequence of seroma re-absorption and tissue re-modelling, thus the tumour bed would be more difficult to identify in this group of patients

Design outcomes

Primary

MeasureTime frame
Mean daily displacement in tumour bed centre of gravity expressed as three-dimensional co-ordinates.

Secondary

MeasureTime frame
1. Mean total displacement in tumour bed centre of gravity during a course of radiotherapy 2. Mean change in tumour bed volume 3. Intra- and inter-observer variability in tumour bed localisation

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026